Willa Clear Skin — Class II drug recall D-0092-2021
Terminated recall by Milbar Laboratories, Inc., reported 2020-11-25, distributed nationwide. GMP Deviations
| Recall number | D-0092-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Milbar Laboratories, Inc., East Haven, CT, United States |
| Recall initiated | 2020-10-09 |
| Classified | 2020-11-17 |
| Reported by FDA | 2020-11-25 |
| Terminated | 2023-01-04 |
| Distributed | Nationwide (US) |
| Quantity | 4,855 tubes |
| Reason classes | cgmp |
| Lot numbers | DW827-4, MAR-22 |
Product
Willa Clear Skin (Salicylic Acid 2%), 4.2 fl oz 124ml tubes, WBC Group LLC, Dist. Chandler, AZ 85226
Reason for recall
GMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0092-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.